Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
CPH:TSE
Cipher Pharmaceuticals Inc
CA$18.47
+1.71%
(+0.31) 1D
Apr 24, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CPH...
Open
CA$18.16
High
CA$18.59
Low
CA$18.16
Mkt. cap
467.83M
Avg. vol.
39.34K
Volume
10.35K
P/E ratio
12.82
52-wk high
CA$19.62
52-wk low
CA$11.87
EPS
CA$1.44
Beta
0.02
Shares outstanding
25.28M
No. of employees
43
News stories
From sources across the web
Investor's Business Daily
Investor's Business Daily
·
31 minutes ago
Market At Highs; Five Titans Lead Earnings
Seeking Alpha
Seeking Alpha
·
40 minutes ago
Bulls Charge Back
MarketBeat
MarketBeat
·
1 hour ago
PLBY Group (NASDAQ:PLBY) CEO Sells $33,858.66 in Stock
bloomingbit
bloomingbit
·
1 hour ago
Nasdaq-Listed Nakamoto Details Bitcoin Derivatives Program
About Cipher Pharmaceuticals Inc
CEO-
Employees43
Founded2000
HeadquartersMississauga, Ontario, Canada
SectorPharmaceutical industry
Websitecipherpharma.com
Last report
Mar 13, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-/ -CAD
Revenue / Estimate
16.64M/ (17.14M est.)CAD
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
12.02M
13.38M
12.83M
12.22M
Cost of goods sold
2.88M
2.50M
2.35M
2.30M
Cost of revenue
2.88M
2.50M
2.35M
2.30M
Research and development expenses
21.00K
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.82M
4.08M
3.71M
3.68M
Operating expense
6.67M
5.89M
5.51M
5.49M
Total operating expenses
9.54M
8.39M
7.86M
7.79M
Operating income
2.47M
4.99M
4.97M
4.43M
Other non operating income
-
-
-
-
EBT including unusual items
1.89M
6.40M
4.26M
4.61M
EBT excluding unusual items
2.02M
6.40M
4.13M
4.84M
Income tax expense
-737.00K
512.00K
-1.24M
-8.70M
Effective tax rate
-39.06%
7.99%
-29.19%
-188.55%
Other operating expenses
-
-
-
-
Net income
2.62M
5.89M
5.50M
13.31M
Net profit margin
21.83%
44.04%
42.87%
108.95%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-470.00K
-345.00K
-241.00K
-109.00K
Net interest expenses
-470.00K
-345.00K
-241.00K
-109.00K
Depreciation and amortization charges
1.82M
1.81M
1.80M
1.81M
EBITDA
4.30M
6.80M
6.77M
5.95M
Gain or loss from assets sale
-
-
-
-130.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer